Compartilhar
Briefings

Session: Redefining Value and Success in Healthcare: Charting the Path to the Future

Across the healthcare industry, we are seeing forward-thinking organizations develop new competencies in anticipation of the opportunity that comes with industry-wide transformation. They are positioning themselves for success. And they are defining the future of healthcare.

Will your organization be ready?
The shift away from volume-based, fee-for-service reimbursement models is fueling widespread transformation throughout the healthcare ecosystem, laying the foundation for a more purposeful and integrated system to emerge. It also means that every member of the healthcare ecosystem must reconsider its strategy, business models and operating structure ultimately redefining what value and success means to each.

Now is the time for healthcare leaders to redefine value for their stakeholders and consumers, and success for their organizations.

Session: IBM Watson: Milestones in Healthcare DeepQA

IBM Watson's ability to analyze the meaning and context of human language, and quickly process vast amounts of information to suggest options targeted to a patient's circumstances, can assist decision makers, such as physicians and nurses, in identifying the best and most effective courses of treatment for their patients. In less than 3 seconds, Watson can sift through the equivalent of about 200 million pages, analyze the information, and provide precise responses. With medical information doubling every 5 years the need for advanced health analytic systems has never been greater. Watson is expected to serve as a powerful ally to the physician's goal of improving patient care through the delivery of up- to-date, evidence-based health care.

Please join Dan Pelino, IBM General Manager, Healthcare & Life Sciences; Dan Cerutti, IBM VP Watson Commercialization; and Steven Shapiro, MD, University of Pittsburgh Medical Center, in a conversation on IBM's efforts to bring Watson capabilities to healthcare.

Session: Fade or flourish?: Rethinking the role of life sciences companies in the healthcare ecosystem

The life sciences industry stands at a crossroads. Its business model is broken, and the surrounding healthcare ecosystem is changing dramatically. So how should companies respond? They can carry on as normal and potentially fade into insignificance or completely rethink how they engage with the other stakeholders in the healthcare ecosystem in an effort to flourish anew. In today's increasingly complex and fast-changing environment, business model innovation is critical to success. Yet few understand when to make a change or - more important - how to execute on.

Join us for this webcast, where we will share the findings from IBM's recently released study ''Fade or flourish?: Rethinking the role of life sciences companies in the healthcare ecosystem''. The study looks at the enormous challenges facing the industry and the changes that organizations are having to consider today and in the future. Finally it considers four fundamental questions driving the strategic direction if life sciences companies over the next decade - their role in the future healthcare ecosystem; the business the company wants to be in; changes to the global innovation model and how to take advantage of growth in the emerging markets.

Session: ICD-10: Significant Changes, Varying Responses, Opportunities Abound

The move from ICD-9 to ICD-10 is clearly significant, with many different options available for response. ICD-10 also represents a new way to think about data analytics - ways to use simulations and predictive modeling on structured and unstructured data for information clarity and decision making. This session will discuss the critical role of data analytics in your ICD-10 transition strategy and discuss real world examples of how analytics can be used to better outcomes and performance.

Session: Innovating for Success: Creating an Agile Patient-centric Healthcare Organization

Healthcare organizations around the world are being pressed to demonstrate greater value, activate consumers to make better health and healthcare choices, and collaborate across the continuum of care. At the same time, they are expected to slow the growth in the cost of care, accept financial risk for patient care, and differentiate themselves to enhance competitiveness. This session discusses implications for care delivery organizations, steps they can take now to place them on the road to success, and examples of how leading healthcare organizations have taken bold steps along that road.

Session: Embedding Analytics: The New Path to Improved Business Performance

New findings from a joint study by the MIT Sloan Management Business Review and the IBM Institute for Business Value indicate that organizations that lead in analytics outperform those that are just beginning to adopt analytics by a factor of three. The analytic approaches of the top performers are changing from reporting on "what happened" to understanding "what's possible" and embedding analytics in the process of decision making. Rather than available data or finances, the primary barriers to using analytics are organizational capacity. This session will make the case for a new generation of analytics and provide a five-point approach to operationalizing analytics to achieve higher levels of business value. Case studies in healthcare and from other industries will illustrate analytic and organizational approaches that work.

Session: The Value of Connected and Personalized Care: Improving Clinical and Business Performance

What quantifiable business value can you realize from your IT investments?

How do these investments drive your hospital's ability to improve the quality of care, increase practitioner effectiveness and improve net revenue?

The IBM Center for Market Insights has recently completed a ground breaking study that quantifies the value a hospital can expect to achieve by realizing a connected and personalized care.

Come hear how Electronic Medical Records, Healthcare Portals, Health Information Exchanges, Health Analytics, and Clinical Decision Support Systems can deliver tangible benefits for your organization.